Han Biomedical Stock

Han Biomedical Liabilities

The The Liabilities of Han Biomedical (6999.TWO) as of Aug 16, 2026 is 23.11 M TWD. In the previous year, The Liabilities was 22.02 M TWD — a change of 4.98% (higher).

Liabilities

23.11 MTWD

YoY

4.98%

Last updated:

In 2026, Han Biomedical's total liabilities amounted to 23.11 M TWD, a 4.98% difference from the 22.02 M TWD total liabilities in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Han Biomedical Stock analysis

What does Han Biomedical do? Han Biomedical is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Han Biomedical's Liabilities

Han Biomedical's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Han Biomedical's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Han Biomedical's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Han Biomedical's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Han Biomedical’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Han Biomedical stock

The Liabilities of Han Biomedical is 23.11 M TWD in 2026.

The Liabilities of Han Biomedical changed from 22.02 M TWD to 23.11 M TWD, representing a 4.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Han Biomedical since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Han Biomedical historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Han Biomedical

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Han Biomedical